PBH Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
336.3M
+26.6%
265.7M
-5.6%
281.6M
-0.6%
283.4M
+3.4%
274.1M
Cost of Revenue
163.8M
+26.4%
129.5M
-4.3%
135.3M
+7.3%
126.1M
+2.9%
122.5M
Gross Profit
172.5M
+26.7%
136.2M
-6.9%
146.3M
-7.0%
157.4M
+3.8%
151.6M
Operating Expenses
91.8M
+9.8%
83.7M
+18.2%
70.8M
-5.4%
74.9M
+4.1%
71.9M
R&D
0
0
0
0
0
SG&A
83.1M
+6.6%
78.0M
+19.3%
65.4M
-6.3%
69.7M
+4.5%
66.7M
Operating Income
80.7M
+53.7%
52.5M
-30.4%
75.5M
-8.5%
82.5M
+3.5%
79.7M
EBITDA
109.9M
+79.3%
61.3M
-26.9%
83.8M
-6.9%
90.1M
+3.1%
87.3M
Net Income
25.3M
-13.3%
29.2M
-45.9%
53.9M
+15.5%
46.7M
+10.6%
42.2M
EPS (Basic)
$0.53
-13.1%
$0.61
-46.5%
$1.14
+16.3%
$0.98
+14.0%
$0.86
EPS (Diluted)
$0.53
-13.1%
$0.61
-46.0%
$1.13
+16.5%
$0.97
+12.8%
$0.86
Shares (Diluted)
47.6M
-0.0%
47.6M
-0.2%
47.7M
-0.8%
48.1M
-2.4%
49.3M
Prestige Consumer Healthcare (PBH) — Financials